Malaria hospitalisation in East Africa: age, phenotype and transmission intensity.
Alice KamauRobert S PatonSamuel AkechArthur MpimbazaCynthia KhazenziMorris OgeroEda MumoVictor A AleganaAmbrose AgweyuNeema MturiShebe MohammedGodfrey BigogoAllan AudiJames KapisiAsadu SserwangaJane F NamugangaSimon KariukiNancy A OtienoBryan O NyawandaAlly OlotuNahya SalimThabit AthumanSalim AbdullaAmina F MohamedGeorge MtoveHugh ReyburnSunetra GuptaJosé LourençoPhilip BejonRobert W SnowPublished in: BMC medicine (2022)
Targeting chemoprevention or vaccination programmes to areas where community-based parasite prevalence is ≥10% is likely to match the age ranges covered by interventions (e.g. intermittent presumptive treatment in infancy to children aged 2-23 months and current vaccine age eligibility and duration of efficacy) and the age ranges of highest disease burden.